Parallel design & Reference-scaling [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2018-09-07 15:27  – Posting: # 19250
Views: 710

Hi Sundar,

» Is it possible to design the reference scaled approach following parallel study (single period)?

By definition reference-scaling is applicable if the within-subject variability of the reference is >30%. CVwR is not accessible in a parallel design (not even CVw…).

» If yes, how to design the study, randomization and statistical procedures?

Tóthfalusi and Endrényi proposed a method for studies in a parallel design.1 However, in a follow-up paper2 they didn’t mention parallel designs any more. Given the troubles we already are facing with replicate designs (inflation of the Type I Error, convergence issues in the partial replicate) I guess the chance of a rather exotic approach to be accepted by any agency is practically zero.


  1. Tóthfalusi L, Endrényi L. An Exact Procedure for the Evaluation of Reference-Scaled Average Bioequivalence. AAPS J. 2016;18(2):476–89. doi:10.1208/s12248-016-9873-6. [image] free resource.
  2. Tóthfalusi L, Endrényi L. Algorithms for evaluating reference scaled average bioequivalence: Power, bias, and consumer risk. Stat Med. 2017;36(27):4378–90. doi:10.1002/sim.7440.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,405 posts in 4,122 threads, 1,323 registered users;
online 8 (0 registered, 8 guests [including 7 identified bots]).
Forum time (Europe/Vienna): 06:21 CEST

[Those] who have an excessive faith in their theories or in their
ideas are not only poorly disposed to make discoveries, but they
also make very poor observations.    Claude Bernard

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5